Company Filing History:
Years Active: 2019-2024
Title: The Innovative Contributions of Inventor Yong Ni
Introduction
Yong Ni, an accomplished inventor based in Wilmington, DE, has made significant strides in the pharmaceutical field, notably in the development of sustained-release dosage forms. With a total of six patents to his name, his work is pivotal in treating various Janus kinase-associated diseases.
Latest Patents
Yong Ni’s recent patent focuses on the creation of sustained-release formulations and dosage forms of ruxolitinib. This invention is particularly valuable for treating myeloproliferative disorders and related conditions, as it provides a more effective means of administering medication over time.
Career Highlights
Throughout his career, Yong Ni has been associated with prominent companies, including Incyte Corporation and Incyte Holdings Corporation. His work at these institutions has allowed him to collaborate on groundbreaking research and contribute to vital advancements in pharmaceuticals.
Collaborations
In his professional journey, Yong has worked alongside notable colleagues such as Bhavnish Parikh and Krishnaswamy Yeleswaram. Their collaborations have resulted in innovative approaches to drug formulation, further enhancing the therapeutic options available for patients.
Conclusion
Yong Ni’s contributions to the field of pharmaceuticals through his inventive patents highlight the importance of innovation in addressing complex medical challenges. As he continues to develop new formulations, his work will undoubtedly influence the future of treatment for various health conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.